Data protection Impressum

Pharma

Why Switzerland

Swiss Biotech Center: innovative solutions for biopharmaceutical development

Limula and CSEM collaborate to make cellular therapies more accessible

13 February 2023

Geneva start-up STALICLA signs exclusive in-licensing agreement with Novartis

16 January 2023

Bachem Group secures CHF 1 billion peptide supply contract

11 January 2023

Lonza uses virtual reality to train and attract talented workers

19 December 2022

Oncology therapeutics specialist Opna Bio raises USD 38 million

23 November 2022

Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million

23 November 2022

The HEIA-FR drives innovation through collaboration

15 November 2022

Sophia Genetics partners with Microsoft to accelerate health data analysis

8 November 2022

Idiap and InflamAlps partner up to accelerate antibiotic research using artificial intelligence

25 October 2022

1 … 5 6 7 8 9 10 11 12 13 14